Clinical trial
Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma
NCT00142025 · Centre of Chinese Medicine, Georgia, Other · Completed
Key facts
| NCT number | NCT00142025 |
|---|---|
| Title | Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma |
| Official title | Randomised, Placebo Controlled, Double Blind, Parallel Group 3-Months Study of Oxcarbazepine Efficacy in Asthma Therapy |
| Lead sponsor | Centre of Chinese Medicine, Georgia, Other |
| Collaborators | Rea Rehabilitation Centre, Georgia |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bronchial Asthma |
| Intervention type | Drug |
| Interventions | Oxcarbazepine |
| Enrollment | 55 |
| Start date | Sep 1, 2001 |
| Completion | Mar 1, 2002 |
| First posted | Sep 2, 2005 |
| Last update posted | Feb 19, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: